ClinicalTrials.Veeva

Menu

AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine

G

Guangzhou University of Traditional Chinese Medicine

Status and phase

Completed
Phase 4

Conditions

Cerebral Infarction

Treatments

Drug: Compound stroke herbal medicine (8 herbal)
Drug: Erigeron breviscapus injection
Drug: hua tuo zai zao wan (a herbal medicine pill)

Study type

Interventional

Funder types

Other

Identifiers

NCT00351806
2004BA721A02

Details and patient eligibility

About

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.

Full description

The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and safety.

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ischemic stroke diagnosis by CT/MRI scan
  • Yin pattern of Traditional Chinese Medicine Theory
  • 40-85 years old
  • Total anterior circulation infarcts (TACI), partial anterior territory cerebral infarction (PACI), lacunar anterior circulation infarcts (LACI) type under Oxfordshire Community Stroke Project (OCSP) standard
  • NIHSS >=4;
  • Glasgow coma scale (GCS) >=7;
  • Modified Rankin Scale less than 2 degrees before onset of this stroke
  • Informed consent signed by patient or his/her family

Exclusion criteria

  • Hemorrhagic stroke;
  • Coma, GCS<=7;
  • Cerebral hernia;
  • Serious heart, liver, lung, kidney functional failure;
  • Gastrointestinal (GI) bleeding;
  • Thrombolysis drugs or surgery was administrated to the patient;
  • Not cooperative with physician;
  • Psychological disorder;
  • Already taken part in other clinical drug trial within the past 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

500 participants in 2 patient groups, including a placebo group

Chinese herbal medicine
Experimental group
Treatment:
Drug: Compound stroke herbal medicine (8 herbal)
Drug: Erigeron breviscapus injection
Drug: hua tuo zai zao wan (a herbal medicine pill)
placebo
Placebo Comparator group

Trial contacts and locations

22

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems